HPVdb: A data mining system for knowledge discovery in human papillomavirus with applications in Tcell immunology and vaccinology

Database

Volumn 2014, Issue , 2014, Pages

  Zhang, Guang Lan ^a,b,c   Riemer, Angelika B ^d   Keskin, Derin B ^a,c   Chitkushev, Lou ^b   Reinherz, Ellis L ^a,c   Brusic, Vladimir ^a,b,c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; VIRUS ANTIGEN; WART VIRUS VACCINE;

AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; CLASSIFICATION; COMPUTER PROGRAM; DATA MINING; GENETIC DATABASE; GENETIC VARIABILITY; HUMAN; IMMUNOLOGY; KNOWLEDGE BASE; METHODOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PAPILLOMA VIRUS; PROTEIN DATABASE; T LYMPHOCYTE; VACCINATION;

AMINO ACID SEQUENCE; ANTIGENS, VIRAL; CONSERVED SEQUENCE; DATA MINING; DATABASES, GENETIC; DATABASES, PROTEIN; EPITOPES, T-LYMPHOCYTE; GENETIC VARIATION; HUMANS; KNOWLEDGE BASES; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS VACCINES; SOFTWARE; T-LYMPHOCYTES; VACCINATION;

EID: 84904153922     PISSN: 17580463     EISSN: None     Source Type: Journal    
DOI: 10.1093/database/bau031     Document Type: Article

References (35)

1. zur Hausen, H. (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer, 2, 342-350.
2. Ganguly, N. and Parihar, S.P. (2009) Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis. J. Biosci., 34, 113-123.
3. de Villiers, E.M. (2013) Cross-roads in the classification of papillomaviruses. Virology, 445, 2-10.
4. Forman, D., de Martel, C., Lacey, C.J. et al. (2012) Global burden of human papillomavirus and related diseases. Vaccine, 30 (Suppl. 5), F12-F23.
5. de Martel, C., Ferlay, J., Franceschi, S. et al. (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol., 3, 607-615.
6. Walboomers, J.M., Jacobs, M.V., Manos, M.M. et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol., 189, 12-19.
7. de Sanjose, S., Quint, W. G., Alemany, L. et al. (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol., 11, 1048-1056.
8. Lehtinen, M. and Dillner, J. (2013) Clinical trials of human papillomavirus vaccines and beyond. Nat. Rev. Clin. Oncol. 10, 400-410.
9. Siddiqui, M.A. and Perry, C.M. (2006) Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil). Drugs, 66, 1263-1271.
10. Keam, S.J. and Harper, D.M. (2008) Human papillomavirus types 16 and 18 vaccine (recombinant, AS04 adjuvanted, adsorbed) [Cervarix]. Drugs, 68, 359-372.
11. Stern, P.L., van der Burg, S.H., Hampson, I.N. et al. (2012) Therapy of human papillomavirus-related disease. Vaccine, 30 (Suppl. 5), F71-F82.
12. Kenter, G.G., Welters, M.J., Valentijn, A.R. et al. (2009) Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N. Engl. J. Med., 361, 1838-1847.
13. Zhang, G.L., Riemer, A., Keskin, D.B. et al. HPVdb: data source and analysis platform for T-cell based vaccine target discovery in human papillomavirus. In: Proceedings of ACM-BCB, 2013. 2013. Washington, DC.
14. Olsen, L.R., Zhang, G.L., Reinherz, E.L., et al. (2011) FLAVIdB: a data mining system for knowledge discovery in flaviviruses with direct applications in immunology and vaccinology. Immunome Res., 7, 1-9.
15. Sollner, J., Heinzel, A., Summer, G. et al. (2010). Concept and application of a computational vaccinology workflow. Immunome Res., 6 (Suppl. 2), S7.
16. UniProt Consortium. (2010) The Universal Protein Resource (UniProt) in 2010. Nucleic Acids Res., 38, D142-D148.
17. Vita, R., Zarebski, L., Greenbaum, J.A. et al. (2010) The immune epitope database 2.0. Nucleic Acids Res., 38, D854-D862.
18. Altschul, S.F., Gish, W., Miller, W. et al. (1990) Basic local alignment search tool. J. Mol. Biol., 215, 403-410.
19. Katoh, K., Misawa, K., Kuma, K. et al. (2002) MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res., 30, 3059-3066.
20. Hoof, I., Peters, B., Sidney, J. et al. (2009) NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetic, 61, 1-13.
21. Nielsen, M., Justesen, S., Lund, O. et al. (2010) NetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure. Immunome Res., 6, 9.
22. Lin, H.H., Zhang, G.L., Tongchusak, S. et al. (2008) Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research. BMC Bioinformatics, 9 (Suppl. 12), S22.
23. Lin, H.H., Ray, S., Tongchusak, S. et al. (2008) Evaluation of MHC class I peptide binding prediction servers: applications for vaccine research. BMC Immunol., 9, 8-20.
24. Shannon, C.E. (1948) A mathematical theory of communication. Bell Syst. Tech. J., 27, 379-423, 623-656.
25. Riemer, A.B., Keskin, D.B., Zhang, G.L. et al. (2010) A conserved E7-derived cytotoxic T lymphocyte epitope expressed on human papillomavirus 16-transformed HLA-A2+ epithelial cancers. J. Biol. Chem., 285, 29608-29622.
26. Keskin, D.B., Reinhold, B., Lee, S.Y. et al. (2011) Direct identification of an HPV-16 tumor antigen from cervical cancer biopsy specimens. Front. Immunol., 2, 75.
27. Reinhold, B., Keskin, D.B., Reinherz, E.L. (2010) Molecular detection of targeted major histocompatibility complex I-bound peptides using a probabilistic measure and nanospray MS3 on a hybrid quadrupole-linear ion trap. Anal. Chem., 82, 9090-9099.
28. van Driel, W.J., Ressing, M.E., Kenter, G.G. et al. (1999) Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial. Eur. J. Cancer, 35, 946-952.
29. Frazer, I.H. (2004) Prevention of cervical cancer through papillomavirus vaccination. Nat. Rev. Immunol. 4, 46-54.
30. Moscicki, A.B., Schiffman, M., Burchell, A. et al. (2012) Updating the natural history of human papillomavirus and anogenital cancers. Vaccine, 30 (Suppl. 5), F24-F33.
31. Stanley, M. (2006) Immune responses to human papillomavirus. Vaccine, 24 (Suppl. 1), S16-S22.
32. Farmer, A.D., Calef, C.E., Millman, K. et al. (1995) The human papillomavirus database. J. Biomed. Sci., 2, 90-104.
33. van Doorslaer, K., Tan, Q., Xirasagar, S. et al. (2013) The Papillomavirus Episteme: a central resource for papillomavirus sequence data and analysis. Nucleic Acids Res., 41, D571-D578.
34. Maes, P., Matthijnssens, J., Rahman, M. et al. (2009) RotaC: a web-based tool for the complete genome classification of group A rotaviruses. BMC Microbiol. 9, 238.
35. Kumar, S., Jena, L., Daf, S. et al. (2013) hpvPDB: an online proteome reserve for human papillomavirus. Genomics Inform. 11, 289-291.